Understanding the research versus pharmaceutical grade distinction is critical here, and navigating the grey market peptide landscape requires extra caution for sublingual products
Yes, Cartalax belongs to the Khavinson class of bioregulatory peptides developed at the Saint Petersburg Institute of Bioregulation and Gerontology in Russia
This peptide has gained attention for its ability to support healing and repair in various tissues, including muscles, tendons, ligaments, bones, skin, and even the digestive tract
It contains a small amount of white lyophilised powder freeze-dried peptide that needs to be dissolved back into solution before it can be used in research
Legal status (US): Sermorelin has a documented, two-part FDA approval history under the brand name Geref, both approvals held by Serono (later EMD Serono)
Unlike topicals, they are said to offer direct, systemic cellular support